UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

Durvalumab (MEDI4736) and Radiosurgery (fSRT vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases

Phase 2

Withdrawn

Conditions: Brain Metastases from Non-small Cell Lung Cancer

Interventions: Radiation: Stereotactic Radiation Therapy
Drug: Durvalumab

First Posted Date: 2021-05-17

Last Posted Date: 2024-12-20

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 46

Registration Number: NCT04889066

A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer

Phase 2

Active, not recruiting

Conditions: Head and Neck Cancer

Interventions: Radiation: Intensity modulated radiation therapy (IMRT) with or without chemotherapy
Drug: cisplatin, cetuximab, or carboplatin-paclitaxel

First Posted Date: 2021-05-12

Last Posted Date: 2024-01-31

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 50

Registration Number: NCT04883281

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Pilot Intervention for Social Biases in Eating Disorders

Not Applicable

Completed

Conditions: Bulimia Nervosa
Eating Disorders
Anorexia Nervosa
Binge-Eating Disorder

Interventions: Behavioral: Self-Blame and Perspective-Taking Intervention

First Posted Date: 2021-05-07

Last Posted Date: 2021-05-07

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 29

Registration Number: NCT04877158

Locations: 🇺🇸
UTSW, Dallas, Texas, United States

Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM)

Completed

Conditions: Ductal Carcinoma in Situ
Prognostic Stage I Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Anatomic Stage IIIA Breast Cancer AJCC v8
BRCA1 Mutation
Anatomic Stage IA Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IIB Breast Cancer AJCC v8

First Posted Date: 2021-04-30

Last Posted Date: 2022-01-21

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 10

Registration Number: NCT04866992

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma

Phase 3

Recruiting

Conditions: Urothelial Carcinoma Ureter
Urothelial Cancer of Renal Pelvis

Interventions: Procedure: sterile water irrigation
Drug: Gemcitabine

First Posted Date: 2021-04-29

Last Posted Date: 2024-12-12

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 132

Registration Number: NCT04865939

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Early Phase 1

Recruiting

Conditions: Hypertension
Obesity

Interventions: Drug: Neuropeptide Y

First Posted Date: 2021-04-09

Last Posted Date: 2024-08-12

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 100

Registration Number: NCT04838678

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma

Not Applicable

Conditions: Renal Cell Carcinoma

Interventions: Procedure: MRI with ASL

First Posted Date: 2021-04-05

Last Posted Date: 2024-04-25

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 90

Registration Number: NCT04831138

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Alcohol Induced de Novo Lipogenesis in Women

Not Applicable

Active, not recruiting

Conditions: Liver Metabolism

Interventions: Other: ETOH
Other: Sucrose

First Posted Date: 2021-04-02

Last Posted Date: 2024-03-22

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 20

Registration Number: NCT04829110

Locations: 🇺🇸
School of Health Professions at UTSW, Dallas, Texas, United States

Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV

Early Phase 1

Recruiting

Conditions: HIV I Infection
Lipid Metabolism Disorders
Cardiovascular Risk Factor

Interventions: Drug: Doravirine 100 Mg

First Posted Date: 2021-03-29

Last Posted Date: 2024-03-12

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 20

Registration Number: NCT04820933

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
University of Texas Southwestern, Dallas, Texas, United States

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

Phase 1

Recruiting

Conditions: Rhabdomyosarcoma
Solid Tumor

Interventions: Drug: Atezolizumab
Drug: Vincristine
Drug: Irinotecan
Drug: Temozolomide

First Posted Date: 2021-03-12

Last Posted Date: 2024-06-12

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 23

Registration Number: NCT04796012

Locations: 🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸
Cincinnati Children's Hospital, Cincinnati, Ohio, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy